1. Home
  2. FCT vs STXS Comparison

FCT vs STXS Comparison

Compare FCT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Senior Floating Rate Income Fund II of Beneficial Interest

FCT

First Trust Senior Floating Rate Income Fund II of Beneficial Interest

N/A

Current Price

$10.04

Market Cap

245.5M

Sector

Finance

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$2.32

Market Cap

210.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCT
STXS
Founded
2004
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.5M
210.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
FCT
STXS
Price
$10.04
$2.32
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
106.8K
428.3K
Earning Date
01-01-0001
11-11-2025
Dividend Yield
11.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$30,075,000.00
Revenue This Year
N/A
$24.48
Revenue Next Year
N/A
$29.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.62
52 Week Low
$9.45
$1.54
52 Week High
$10.42
$3.59

Technical Indicators

Market Signals
Indicator
FCT
STXS
Relative Strength Index (RSI) 68.80 42.57
Support Level $9.99 $2.32
Resistance Level $10.07 $2.42
Average True Range (ATR) 0.10 0.09
MACD 0.06 0.02
Stochastic Oscillator 92.55 42.00

Price Performance

Historical Comparison
FCT
STXS

About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest

First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: